Exosect to present benefits of Entostat technology in delivering biostimulants

13th May 2015

Winchester, UK – Exosect Ltd., a leading provider of enabling technologies, today announced that its Chief Technology Officer, Dr. Aoife Dillon, will be speaking at the Biostimulants and Plant Growth Conference, to be held in Brussels next week between 18-21st May*.

The presentation, entitled, ‘Innovation in formulation and delivery of biostimulants’, will provide an insight into the ability of Exosect’s proprietary platform technology, Entostat, to efficiently deliver biological active ingredients. The presentation will focus on the delivery of biostimulants as a seed treatment and will discuss how the characteristics of Entostat enable a more targeted and efficient delivery of biologically active ingredients.

 

                                                                 Ends

 

Notes to Editors

*Biostimulants and Plant Growth – Informa Life Sciences
18-21st May 2015, Le Plaza Hotel, Brussels

For further information please contact: Georgina Donovan at Exosect. 

Tel: 02380 603939 or email: georgina.donovan@exosect.com

 

 

Contact us: Send us an enquiry or call +44(0)845 199 5540